Medical Writing in India

A trial finishes and produces 8,000 pages of raw data. You write the documents that synthesise it: the Clinical Study Report (CSR, ICH E3), the Investigator's Brochure, the patient narratives, the Common Technical Document (CTD) summaries, the Periodic Safety Update Report (PSUR/PBRER), and — on the publications side — the journal manuscripts and conference posters. Two career tracks live under the same name: regulatory medical writing (RMW) for filings, and medical communications (MedComms) for journals + KOL slide decks.

Every trial needs writers, every approved drug needs PSURs forever, and every pharma launch needs publications + KOL training material. India runs ~50% of MNC pharma's regulatory writing offshore (NASSCOM 2025) and the MedComms agency market in India has tripled since 2020.

Global medical writing market: ~$5.5B in 2025, projected $9B by 2029; India captures ~30% of offshore execution (Grand View + NASSCOM).

Who fits: B.Pharm, M.Pharm, Pharm.D, M.Sc Life Sciences, MBBS, BDS, BAMS, BHMS, MD/MS. Strong written English is the entire job — non-negotiable. Publication writing also values prior journal authorship.

1. Step 1Y0

   Medical Writer L1 (Narratives / Manuscripts)

   ₹4 – 6.5 LPA

   Unlock: AMWA basics + 50 patient narratives or 3 manuscript drafts on resume

2. Step 2Y2

   Medical Writer L2 (CSR sections / Posters)

   ₹7 – 11 LPA

   Unlock: First full CSR section ownership or first lead-author publication

3. Step 3Y5

   Senior Medical Writer (PSUR / Lead manuscript)

   ₹12 – 19 LPA

   Unlock: EMWA Advanced or ISMPP CMPP + sponsor-facing role

4. Step 4Y8+

   Principal Writer / Scientific Comms Lead

   ₹22 – 36 LPA

   Unlock: Owns therapeutic-area portfolio + KOL strategy + writer team

• Medical Writer L1 (RMW)
• Medical Writer (MedComms / Publications)
• Senior Medical Writer (CSR / PSUR)
• Scientific Communications Lead
• Principal Medical Writer / Lead
• Medical Editor / QC Reviewer

• AMWA Essential Skills certificate

  +₹80k-1.2L at offer; the recognised entry credential

• EMWA Foundation / Advanced

  +₹1L; favoured by EU-aligned pharma and CROs

• ISMPP CMPP (publications)

  +₹1.2L; gates senior MedComms roles

• RMW (regulatory) vs MedComms (publications) — which pays better?

  RMW pays ~10-15% higher at every band because regulator-facing work is higher liability. MedComms is more flexible (remote, agency culture) and has a faster ladder for strong writers. Pick RMW for stability, MedComms for variety.

• MBBS / MD doing medical writing — overqualified?

  No. MDs lead the highest-paying senior roles (₹25-40 LPA at Y6) because therapeutic-area depth speeds up CSRs and lifts manuscript quality. Many MDs use MW as the route into pharma without practising clinically.

• Is a writing sample required for the first job?

  Yes. Most MW interviews end with a 4-8 hour writing test (rewrite a methods section, summarise a results table). Coursework + 2-3 polished writing samples (a journal-style summary, a patient narrative draft) are the entry portfolio.

• Will AI take medical writing jobs?

  AI compresses the bottom of the pyramid (narrative drafting, table shells) but expands senior demand because audit + sponsor-style + regulator defence cannot be automated. Net effect: fewer L1 hires per project, more senior writers per portfolio. Plan for the senior track from Day 1.

• Can a non-pharmacy graduate get in?

  Possible but harder. M.Sc Life Sciences with strong English and a published review article gets L1 offers. MBBS/MD/Pharm.D have the easiest route. Pure English-major candidates almost never clear the medical-content test.

• Best abroad route for writers?

  UK and Ireland. Both have structural writer shortages and accept India-trained writers at Y4+. EMWA + 4 yrs CSR/PSUR experience + Skilled Worker visa is the standard formula. Singapore is the APAC alternative.